Meeting: TrustBoard meeting in public / Date:30 July 2015
Report Title:Research and Development Report 2015
Agenda Item:TB/15-16/044 / Enclosures:none
Report Author:Dr Lona Lockerbie / Presenter: Dr Lona Lockerbie, formerly Trust lead for R & D
Report History:six-monthly / Board Lead: Dr Catherine Kinnane, Medical Director
Purpose of the Report
Six- monthly report / Performance
Policy
Assurance
Strategy / 
Strategic Objective
1 / Enhance service user engagement and patient experience / 
2 / Become an exemplary employer, enabling staff to reach their full potential / 
3 / Ensure sound financial management without compromising the quality of care / 
4 / Develop dynamic and innovative clinical models, enhancing the quality, safety and effectiveness of services / 
5 / Maintain and further establish our position as the provider of choice for mental health services / 
6 / Enhance the quality and safety of the services by maintaining or exceeding required standards of care / 
7 / Incorporate sustainability and environmental management as an essential element of healthcare delivery
Corporate Impact Assessment:
Legal or regulatory implications / Nil
Financial or resource implications / Currently R & D is funded by the CRN. KMPT host the CRN research team.
Engagement / Consultation / N/A
Risks identified / Introduction:
If KMPT doesn’t engage in R & D it will fail to offer forensic service users the opportunity to engage in R & D. Also KMPT will be a less attractive place to work and this may have a deleterious impact on recruitment. Similarly, in tenders and business cases. KMPT may be less attractive than research active competitors.
Specific risks identified:
  1. The impact of the research strategy on the application for Foundation Trust status requires active consideration.
  2. The need to continue to build R&D capacity in order to attract research funding.
  3. The need to continue to meet national guidelines in relation to the governance of R&D.
  4. Lack of R & D funding reduces capacity for research activity.
  5. Kent CLRN has joined Surrey &Sussex CLRN, to form the Clinical Research Network: Kent, Surrey & Sussex (CRN:KSS) hence increased competition for limited funds.

Links to the Board Assurance Framework or Risk Register / See above
Impact on Quality / R & D has a direct impact on quality and evidence based practice.
Equality & Diversity / Without R & D, service users in Kent would not have equal access to participate in research as service users across the county.
  1. All service users should have the opportunity to engage in high quality research.
  2. Lack of research activity will reduce opportunities for patients and KMPT to participate.
  3. Raised research activity across the Service Lines and geographically.

Recommendation / Action required
That the Board notes the good progress made in increasing research activity in KMPT, and supports the preliminary steps to develop a funded KMPT research team starting with the development of the R & D manager’s post. / Approval
Discussion
Consideration
Noting / 
Information
Summary
The Research Strategy to increase research activity across the Trust is being met. We exceeded the 2014/2015 recruitment target of 250, recruiting356 service users to National Institute for Health Research (NIHR)adopted research studies. We are well underway to meet this year’s target of 300. We are attracting interest from commercial studies and have 2 additional industry studies in feasibility / set up for 2015. Our academic relationships continue to strengthen.
Research Activity
The Research Strategy for the Trust identified in stetwas to increase activity in NIHR portfolio studies. Twenty nine such studies were active over the past year
Acronym / Diagnosis / Service / Service Line(s) / Status in 2014/2015 / Recruitment / target
1 / ALTO / Schizophrenia / Acute, Community / Closed June ‘14 / 8/5
2 / AMICUS / Schizophrenia / CRSL, Forensic / Closed Dec ‘14 / 0/15
3 / ASPI / Anxiety in Parents / Acute, CRSL, Specialist / Closed May ‘14 / 4/5
4 / BDR / Dementia / Older Adults / Open / 13/(no target)
5 / CIRCLE / Psychosis and Cannabis / CRSL / Open / 9/5
6 / CLEMATIS / Down Syndrome / Community / Open / 0/2
7 / CODES / Dissociative Seizures / Specialist / In Set Up
8 / COMQUOL / Forensic / Forensic / In Follow Up / 48/16
9 / DPIM / Bipolar Disorder / Schizophrenia / ALL / Open / 67/50
10 / E-Siblings / First Episode Psychosis / CRSL / Open / 5/5
11 / ESMI / Postpartum Depression / Specialist / In Set Up
12 / EULAST / Schizophrenia / ALL / In Set Up
13 / Evaluation of PBS / LD / CRSL / In Follow Up / 70/60
14 / EYE Phase 3a / First Episode Psychosis / CRSL / Open / 32/35
15 / FIPMO / Fire Setting in Forensic Patients / Forensic / In Follow Up / 14/15
16 / GET SET / Chronic Fatigue Syndrome / Specialist / Closed Dec ‘14 / 102/30
17 / GREAT / Dementia / Older Adults / In Set Up
18 / Homicide / Homicide by Patients / ALL / Open / (no target)
19 / IDEAL / Dementia / Older Adults / Open / 64/500
20 / Letting the Future In / Childhood Abuse in MH / CRSL / Closed Nov ‘14 / 7/ (no target)
21 / LonDownS / Learning Disability and Dementia / CRSL,
Older Adults / In Set Up / 0/5
22 / MADE / Dementia / Older Adults / In Set Up / 0/10
23 / MIFCOG / Addictions / Specialist / On Hold / 0/15
24 / NCISH / Schizophrenia / ALL / Open / 27 /(no target)
25 / OFFSCA – ID / Forensic Learning Disability / Forensic / Open / 4/5
26 / PROMS(MAS) / Dementia / Older Adults / Open / 56/75
27 / SHARED / Eating Disorders / Specialist / Open / 1/5
28 / SUDS / Inpatient Sudden Death / Acute / Open / 7/(no target)
29 / VoRAMSS / Risk Assessment-Forensic / Forensic / Open / 38/(no target)
Last year’s strategy was to increase activity in Industry and Commercial Studies. We achieved this with attracting fourindustry studies.
Acroynm / Diagnosis / Service Line(s) / Recruitment status 14-15
ALTO / Schizophrenia / Acute / CRSL / In follow Up Recruited 8/ Target 5
BREX-AD / Dementia / Older Adults / In set up – Opened 2015
EULAST / Schizophrenia / Acute / CRSL/ / In set up – Opened 2015
CLEMATIS / Down Syndrome / CRSL / Opened October 2014
For the ALTO study, with Dr Sawa as Principal Investigator (PI), KMPT recruited the first participant in the UK and achieved the third highest recruitment total out of 21 Mental Health Trusts in the UK.
Dr Lucy Elias was selected as the Chief Investigator (CI) for an International Dementia Study, consequently KMPT is the lead for the UK and Dr Elias has become the first KMPT staff member in the Mental Health Older Adults Services to achieve CI status. This study is an industry care home drug trial and is a first for portfolio research in the UK.
Dr Mo Eyeoyibo was also chosen as CI for an International study into Down Syndrome and therefore becomes the first CRSL staff member to achieve this. KMPT are the lead site for this Phase II study, another first for the Trust.
Dr Lockerbie, Professor Gannon, Dr Tyler and the Kent Fire Service were awarded ‘Best Research’ in the faculty of social sciences by Kent University for the Fip-Mo, fire setting research, an NIHR portfolio study which was designed here in KMPT and has been recruiting in Trusts across the country..
KMPT is clearly demonstrating success in its strategy to increase Portfolio and Commercial study activity.
Research Team
The Clinical Research team continues to befunded by the CRN:KSS and hosted by the Forensic Specialist Service Line based at the Trevor Gibbens Unit. The team were successfully awarded Department of Health Research funding which allowed them to increase from a team of 4 to a team of 9 staff. Their role is specifically to support the portfolio and commercial studies above.
Sarah Dickens has been seconded for a 3 month period into a new role both managing the team but also taking on the role as the Trust R & D manager. The intention is to extend the secondment until the end of March 2016. During this time it is hoped to develop a successful business case to make this permanent.
Service User Involvement
The Expert by Experience Group (EbyE)continues to have representation at the Trust R&D Group. There are now regular meetings between the EbyE group and the Research team. The research team have provided a series of R & D training sessions and are continuing to support the EbyE group to develop.
Partnerships
KMPT to continue to strengthen their partnerships with Canterbury Christ Church University (CCCU) and Kent University.
KMPT is in partnership with CCCU, bidding for a NIHR fellowship for a Clinical Psychologist. There are extremely prestigious awards for Trusts and if successful, KMPT will be one of the first Trusts to be awarded this grant for non-medical research.
The results of the COMQUOL study, developed between CCCU and KMPT will be published this year.
Kent University and the Forensic Service continue to build on their partnership and have now developed a joint Research Associate position. This will ensure the fire setting research continues.
Clinical Research Network (CRN)
We continue to be integrated into the CRN:KSS;. Dr Helen Miles continues the role of Mental Health Speciality Group lead for the CRN:KSS and Dr Kinane representing KMPT on the CRN Board. Sarah Dickens also represents KMPT as part of the CRN R&D Forum and CRN:KSS Workforce Development Steering Group.
Recommendation
That the Board notes the good progress made in increasing research activity in KMPT, and supports the preliminary steps to develop a funded KMPT research team starting with the development of the R & D manager’s post.

1